Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$778M |
| 2 |
Walt Disney
DIS
|
+$575M |
| 3 |
Amazon
AMZN
|
+$558M |
| 4 |
Applied Materials
AMAT
|
+$373M |
| 5 |
eBay
EBAY
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$669M |
| 2 |
Philip Morris
PM
|
+$454M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 4 |
Marvell Technology
MRVL
|
+$371M |
| 5 |
Qualcomm
QCOM
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.2% |
| 2 | Financials | 10.85% |
| 3 | Healthcare | 9.88% |
| 4 | Industrials | 8.88% |
| 5 | Consumer Discretionary | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Trevi Therapeutics
TRVI
$2.54B
| $74.5K | ﹤0.01% |
+21,608
| New | +$48.2K |
|
|
GRFS
3727
Grifois
GRFS
$5.35B
| $70.1K | ﹤0.01% |
10,497
-111,224
| -91% | -$868K |
|
|
NOVA
3728
DELISTED
Sunnova Energy
NOVA
| $68.7K | ﹤0.01% |
11,200
-25,705
| -70% | -$232K |
|
3729
Gabelli Equity Trust
GAB
$1.77B
| $68.4K | ﹤0.01% |
12,390
+2,333
| +23% | +$12.3K |
|
3730
Amneal Pharmaceuticals
AMRX
$6.02B
| $67.3K | ﹤0.01% |
11,109
-70,931
| -86% | -$400K |
|
3731
GrowGeneration
GRWG
$88.3M
| $64K | ﹤0.01% |
22,395
-14,459
| -39% | -$33.3K |
|
|
PNST
3732
DELISTED
Pinstripes Holdings, Inc.
PNST
| $62.4K | ﹤0.01% |
+19,200
| New | +$77.1K |
|
|
ME
3733
DELISTED
23andMe Holding Co
ME
| $59.7K | ﹤0.01% |
5,611
+4,220
| +303% | +$54.3K |
|
3734
Personalis
PSNL
$1.41B
| $59.5K | ﹤0.01% |
+39,948
| New | +$61.9K |
|
|
BIG
3735
DELISTED
Big Lots, Inc.
BIG
| $58.2K | ﹤0.01% |
13,448
-14,071
| -51% | -$74.4K |
|
3736
Archer Aviation
ACHR
$3.69B
| $58.2K | ﹤0.01% |
12,595
-7,864
| -38% | -$39.5K |
|
3737
Gerdau
GGB
$9.93B
| $56.9K | ﹤0.01% |
+15,440
| New | +$55.9K |
|
|
SJT
3738
San Juan Basin Royalty Trust
SJT
$113M
| $55.3K | ﹤0.01% |
10,459
-203
| -2% | -$1.06K |
|
3739
TherapeuticsMD
TXMD
$23.6M
| $51.5K | ﹤0.01% |
22,470
-9
| -0% | -$21 |
|
|
LONA
3740
LeonaBio Inc
LONA
$70.2M
| $50.1K | ﹤0.01% |
+1,827
| New | +$58K |
|
3741
Lufax Holding
LU
$1.31B
| $47K | ﹤0.01% |
+11,135
| New | +$31.2K |
|
|
BGFV
3742
DELISTED
Big 5 Sporting Goods
BGFV
| $45.7K | ﹤0.01% |
12,970
-2,124
| -14% | -$10.2K |
|
|
MTTR
3743
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $45.1K | ﹤0.01% |
19,964
-8,348
| -29% | -$18.3K |
|
3744
ChargePoint
CHPT
$143M
| $43.1K | ﹤0.01% |
1,135
-88
| -7% | -$3.45K |
|
3745
Clean Energy Fuels
CLNE
$410M
| $40.3K | ﹤0.01% |
15,052
-2,098
| -12% | -$6.26K |
|
|
OMGA
3746
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $39.2K | ﹤0.01% |
+10,750
| New | +$41.2K |
|
|
CMLS
3747
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $37.5K | ﹤0.01% |
10,439
| – | – |
|
3748
Lineage Cell Therapeutics
LCTX
$277M
| $35K | ﹤0.01% |
23,660
-2,000
| -8% | -$2.27K |
|
3749
Denison Mines
DNN
$2.61B
| $34.1K | ﹤0.01% |
17,500
| – | – |
|
3750
CEL-SCI Corp
CVM
$21.8M
| $29.6K | ﹤0.01% |
517
| – | – |
|
Similar funds
Ameriprise's Q1 2024 Portfolio in Review
As of Q1 2024, Ameriprise held 4,016 positions worth $363B, up 8.8% from $334B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Ameriprise's Q1 2024 filing shows 118 new, 1,585 increased, 2,002 reduced and 175 closed positions. Its largest new stake was Arcadium Lithium plc: 13,685,562 shares worth $59M. The largest sale was Lam Research, an estimated $669M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2024 buy was Arcadium Lithium plc: 13,685,562 shares worth $59M.
- Ameriprise added most to Meta Platforms (Facebook) in Q1 2024, an estimated $778M increase.
- Ameriprise's biggest Q1 2024 reduction was Lam Research, cutting an estimated $669M.
- Ameriprise fully exited Livent Corporation in Q1 2024, selling an estimated $120M.
- Ameriprise's ten largest holdings make up 18% of its $363B portfolio in Q1 2024.
- Ameriprise opened 118 new positions and closed 175 in Q1 2024.
- Ameriprise's portfolio value rose 8.8% quarter-over-quarter to $363B.
Based on Ameriprise's 13F filing for Q1 2024, filed 15 May 2024.